lobbying_activities: 824874

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
824874	81604c48-a469-492b-bff2-49edf3925d9c	Q3	ENDO INTERNATIONAL	40011075	ENDO INTERNATIONAL	2009	third_quarter	CPT	Supported efforts to address issues of inequitable conduct, timing of patent challenges, and damages in Patent Reform Act of 2009 (H.R. 1260 & S. 515); patent settlement issues in Protecting Consumer Access to Generic Drugs Act of 2009 (H.R. 1706) and Preserve Access to Affordable Generics Act (S. 369).	Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE		530000	0	0	2009-10-12T09:15:28-04:00